第1天 | 第2天 |
糖尿病的創藥
2型糖尿病在全世界廣泛可見中，在糖尿病創藥領域正進行熱烈的研究，為了不落人後，我們也安排許多應討論的主題。針對2型糖尿病的創藥和藥劑開發領域的風險與進展，可與同業者進行討論。透過在講台的發表和由專家主持的專題討論會、討論會等，可談論下一代的糖尿病治療藥等級、口服糖尿病治療候選藥臨床的發展、胰島素感受性或血糖值下降之標的有效性、以及前臨床開發之新標的等話題。
11月3日 星期四
1:30 pm Chairperson’s Remarks
1:40 FEATURED PRESENTATION:
Inhibiting Glucose Transporters via SGLT inhibitors – the Next New Diabetes Drug Family?
Michael Mark, Ph.D., Vice President, CardioMetabolic Diseases Research, Boehringer Ingelheim
This presentation will provide an update on diabetes drug candidates in late stage development, with a focus on compounds targeting sodium glucose transporters. Current challenges faced in the field of diabetes drug development will also be covered.
|
2:25 FEATURED PRESENTATION:
Diabetes Drug Targets from Gastric Bypass Surgery
 Lee M. Kaplan, M.D., Ph.D., Professor, Harvard Medical School
|
3:10 Networking Refreshment Break in the Exhibit Hall with Poster Viewing
3:45 A Physician’s Perspective on the Future of Diabetes Treatments
Rohit N. Kulkarni, M.D., Ph.D., Associate Professor, Medicine, Harvard Medical School; Investigator, Joslin Diabetes Center
This presentation will discuss the scope of the global diabetes problem and which types of diabetes treatments are most needed from a diabetes physician’s and his patients’ perspective to help provide a relevant context to scientists developing new diabetes treatments.
4:15 Sponsored Presentations (Opportunities Available)
4:45 Diabetes Market Landscape
Kelly Close, MBA, President, Close Concerns
5:15 Panel Discussion: Diabetes Drug Development
Moderator: Rebecca Taub, M.D., Senior Vice President, Research and Development, VIA Pharmaceuticals
Developing diabetes drugs in Asia – how is it different? Is that the future? What will clinical trials look like five years from now? What is the ideal diabetes treatment regimen?
|
5:45 End of Day
第1天| 第2天 |
